Circular RNAs and Bladder Cancer

References

• Ploeg M, Aben KK, Kiemeney LA. The present and future burden of urinary bladder cancer in the world. World J Urol. 2009;27(3):289–293. doi:10.1007/s00345-009-0383-319219610
   PubMed Web of Science ®Google Scholar
• Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–2917. doi:10.1002/ijc.2551621351269
   PubMed Web of Science ®Google Scholar
• Zhu G, Pei L, Li Y, Gou X. EP300 mutation is associated with tumor mutation burden and promotes antitumor immunity in bladder cancer patients. Aging. 2020;12(3):2132–2141. doi:10.18632/aging.10272832012118
   PubMedGoogle Scholar
• Witjes JA, Bruins HM, Cathomas R, et al. European association of urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines. Eur Urol. 2020. doi:10.1016/j.eururo.2020.03.055
   Web of Science ®Google Scholar
• Pang C, Guan Y, Li H, Chen W, Zhu G. Urologic cancer in China. Jpn J Clin Oncol. 2016;46(6):497–501. doi:10.1093/jjco/hyw03427049022
   PubMed Web of Science ®Google Scholar
• Zhao F, Lin T, He W, et al. Knockdown of a novel lincRNA AATBC suppresses proliferation and induces apoptosis in bladder cancer. Oncotarget. 2015;6(2):1064–1078. doi:10.18632/oncotarget.283325473900
   PubMedGoogle Scholar
• Chen LL, Yang L. Regulation of circRNA biogenesis. RNA Biol. 2015;12(4):381–388. doi:10.1080/15476286.2015.102027125746834
   PubMed Web of Science ®Google Scholar
• Suzuki H, Tsukahara T. A view of pre-mRNA splicing from RNase R resistant RNAs. Int J Mol Sci. 2014;15(6):9331–9342. doi:10.3390/ijms1506933124865493
   PubMed Web of Science ®Google Scholar
• Jeck WR, Sorrentino JA, Wang K, et al. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA. 2013;19(2):141–157. doi:10.1261/rna.035667.11223249747
   PubMed Web of Science ®Google Scholar
• Salzman J, Chen RE, Olsen MN, Wang PL, Brown PO. Cell-type specific features of circular RNA expression. PLoS Genet. 2013;9(9):e1003777. doi:10.1371/journal.pgen.100377724039610
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang XO, Chen T, et al. Circular intronic long noncoding RNAs. Mol Cell. 2013;51(6):792–806. doi:10.1016/j.molcel.2013.08.01724035497
   PubMed Web of Science ®Google Scholar
• Huang A, Zheng H, Wu Z, Chen M, Huang Y. Circular RNA-protein interactions: functions, mechanisms, and identification. Theranostics. 2020;10(8):3503–3517. doi:10.7150/thno.4217432206104
   PubMed Web of Science ®Google Scholar
• Zaiou M. Circular RNAs as potential biomarkers and therapeutic targets for metabolic diseases. Adv Exp Med Biol. 2019;1134:177–191.30919338
   PubMed Web of Science ®Google Scholar
• Kristensen LS, Andersen MS, Stagsted LVW, Ebbesen KK, Hansen TB, Kjems J. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20(11):675–691. doi:10.1038/s41576-019-0158-731395983
   PubMed Web of Science ®Google Scholar
• Liang D, Tatomer DC, Luo Z, et al. The output of protein-coding genes shifts to circular RNAs when the pre-mRNA processing machinery is limiting. Mol Cell. 2017;68(5):940–954 e3. doi:10.1016/j.molcel.2017.10.03429174924
   PubMed Web of Science ®Google Scholar
• Kelly S, Greenman C, Cook PR, Papantonis A. Exon skipping is correlated with exon circularization. J Mol Biol. 2015;427(15):2414–2417. doi:10.1016/j.jmb.2015.02.01825728652
   PubMed Web of Science ®Google Scholar
• Zhang XO, Wang HB, Zhang Y, Lu X, Chen LL, Yang L. Complementary sequence-mediated exon circularization. Cell. 2014;159(1):134–147. doi:10.1016/j.cell.2014.09.00125242744
   PubMed Web of Science ®Google Scholar
• Conn SJ, Pillman KA, Toubia J, et al. The RNA binding protein quaking regulates formation of circRNAs. Cell. 2015;160(6):1125–1134. doi:10.1016/j.cell.2015.02.01425768908
   PubMed Web of Science ®Google Scholar
• Eger N, Schoppe L, Schuster S, Laufs U, Boeckel JN. Circular RNA splicing. Adv Exp Med Biol. 2018;1087:41–52.30259356
   PubMed Web of Science ®Google Scholar
• Sen R, Ghosal S, Das S, Balti S, Chakrabarti J. Competing endogenous RNA: the key to posttranscriptional regulation. ScientificWorldJournal. 2014;2014:896206. doi:10.1155/2014/89620624672386
   PubMed Web of Science ®Google Scholar
• Li X, Xu M, Ding L, Tang J. MiR-27a: a novel biomarker and potential therapeutic target in tumors. J Cancer. 2019;10(12):2836–2848. doi:10.7150/jca.3136131258791
   PubMed Web of Science ®Google Scholar
• Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 2017;16(3):203–222. doi:10.1038/nrd.2016.24628209991
   PubMed Web of Science ®Google Scholar
• Acunzo M, Romano G, Wernicke D, Croce CM. MicroRNA and cancer–a brief overview. Adv Biol Regul. 2015;57:1–9. doi:10.1016/j.jbior.2014.09.01325294678
   PubMedGoogle Scholar
• Sun Z, Shi K, Yang S, et al. Effect of exosomal miRNA on cancer biology and clinical applications. Mol Cancer. 2018;17(1):147. doi:10.1186/s12943-018-0897-730309355
   PubMed Web of Science ®Google Scholar
• Sanger HL, Klotz G, Riesner D, Gross HJ, Kleinschmidt AK. Viroids are single-stranded covalently closed circular RNA molecules existing as highly base-paired rod-like structures. Proc Natl Acad Sci U S A. 1976;73(11):3852–3856. doi:10.1073/pnas.73.11.38521069269
   PubMed Web of Science ®Google Scholar
• Lopez-Jimenez E, Rojas AM, Andres-Leon E. RNA sequencing and prediction tools for circular RNAs analysis. Adv Exp Med Biol. 2018;1087:17–33.30259354
   PubMed Web of Science ®Google Scholar
• Wang Y, Mo Y, Gong Z, et al. Circular RNAs in human cancer. Mol Cancer. 2017;16(1):25. doi:10.1186/s12943-017-0598-728143578
   PubMed Web of Science ®Google Scholar
• Bi J, Liu H, Cai Z, et al. Circ-BPTF promotes bladder cancer progression and recurrence through the miR-31-5p/RAB27A axis. Aging. 2018;10(8):1964–1976. doi:10.18632/aging.10152030103209
   PubMedGoogle Scholar
• Yu Q, Liu P, Han G, Xue X, Ma D. CircRNA circPDSS1 promotes bladder cancer by down-regulating miR-16. Biosci Rep. 2020;40(1). doi:10.1042/BSR20191961
   Web of Science ®Google Scholar
• Zhang WY, Liu QH, Wang TJ, Zhao J, Cheng XH, Wang JS. CircZFR serves as a prognostic marker to promote bladder cancer progression by regulating miR-377/ZEB2 signaling. Biosci Rep. 2019;39(12). doi:10.1042/BSR20192779
   Google Scholar
• Chen X, Chen RX, Wei WS, et al. PRMT5 circular RNA promotes metastasis of urothelial carcinoma of the bladder through sponging miR-30c to induce epithelial-mesenchymal transition. Clin Cancer Res. 2018;24(24):6319–6330. doi:10.1158/1078-0432.CCR-18-127030305293
   PubMed Web of Science ®Google Scholar
• Xu ZQ, Yang MG, Liu HJ, Su CQ. Circular RNA hsa_circ_0003221 (circPTK2) promotes the proliferation and migration of bladder cancer cells. J Cell Biochem. 2018;119(4):3317–3325. doi:10.1002/jcb.2649229125888
   PubMed Web of Science ®Google Scholar
• Tang G, Xie W, Qin C, et al. Expression of circular RNA circASXL1 correlates with TNM classification and predicts overall survival in bladder cancer. Int J Clin Exp Pathol. 2017;10(8):8495–8502.31966702
   PubMed Web of Science ®Google Scholar
• Zhuang C, Huang X, Yu J, Gui Y. Circular RNA hsa_circ_0075828 promotes bladder cancer cell proliferation through activation of CREB1. BMB Rep. 2020;53(2):82–87. doi:10.5483/BMBRep.2020.53.2.05931072448
   PubMed Web of Science ®Google Scholar
• Song Z, Zhang Q, Zhu J, Yin G, Lin L, Liang C. Identification of urinary hsa_circ _0137439 as potential biomarker and tumor regulator of bladder cancer. Neoplasma. 2020;67(1):137–146. doi:10.4149/neo_2018_181214N97031777254
   PubMed Web of Science ®Google Scholar
• Liu H, Bi J, Dong W, et al. Invasion-related circular RNA circFNDC3B inhibits bladder cancer progression through the miR-1178-3p/G3BP2/SRC/FAK axis. Mol Cancer. 2018;17(1):161. doi:10.1186/s12943-018-0908-830458784
   PubMedGoogle Scholar
• Dong W, Bi J, Liu H, et al. Circular RNA ACVR2A suppresses bladder cancer cells proliferation and metastasis through miR-626/EYA4 axis. Mol Cancer. 2019;18(1):95. doi:10.1186/s12943-019-1025-z31101108
   PubMedGoogle Scholar
• Su Y, Feng W, Shi J, Chen L, Huang J, Lin T. circRIP2 accelerates bladder cancer progression via miR-1305/Tgf-beta2/smad3 pathway. Mol Cancer. 2020;19(1):23. doi:10.1186/s12943-019-1129-532019579
   PubMed Web of Science ®Google Scholar
• Lu Q, Liu T, Feng H, et al. Circular RNA circSLC8A1 acts as a sponge of miR-130b/miR-494 in suppressing bladder cancer progression via regulating PTEN. Mol Cancer. 2019;18(1):111. doi:10.1186/s12943-019-1040-031228937
   PubMed Web of Science ®Google Scholar
• Li Y, Zheng F, Xiao X, et al. CircHIPK3 sponges miR-558 to suppress heparanase expression in bladder cancer cells. EMBO Rep. 1646-1659;2017(18):9.
   Google Scholar
• Li M, Wang Y, Liu Y, Zhang X, Liu J, Wang P. Low expression of hsa_circ_0018069 in human bladder cancer and its clinical significance. Biomed Res Int. 2019;2019:9681863.30984788
   PubMed Web of Science ®Google Scholar
• Yan D, Dong W, He Q, et al. Circular RNA circPICALM sponges miR-1265 to inhibit bladder cancer metastasis and influence FAK phosphorylation. EBioMedicine. 2019;48:316–331. doi:10.1016/j.ebiom.2019.08.07431648990
   PubMed Web of Science ®Google Scholar
• Bi J, Liu H, Dong W, et al. Circular RNA circ-ZKSCAN1 inhibits bladder cancer progression through miR-1178-3p/p21 axis and acts as a prognostic factor of recurrence. Mol Cancer. 2019;18(1):133. doi:10.1186/s12943-019-1060-931481066
   PubMed Web of Science ®Google Scholar
• Abulizi R, Li B, Zhang CG. Circ_0071662, a novel tumor biomarker, suppresses bladder cancer cell proliferation and invasion by sponging miR-146b-3p. Oncol Res. 2019. doi:10.3727/096504019X15740729375088
   PubMedGoogle Scholar
• Li Y, Wan B, Liu L, Zhou L, Zeng Q. Circular RNA circMTO1 suppresses bladder cancer metastasis by sponging miR-221 and inhibiting epithelial-to-mesenchymal transition. Biochem Biophys Res Commun. 2019;508(4):991–996. doi:10.1016/j.bbrc.2018.12.04630551873
   PubMed Web of Science ®Google Scholar
• Shen C, Wu Z, Wang Y, et al. Downregulated hsa_circ_0077837 and hsa_circ_0004826, facilitate bladder cancer progression and predict poor prognosis for bladder cancer patients. Cancer Med. 2020;9(11):3885–3903. doi:10.1002/cam4.300632250047
   PubMed Web of Science ®Google Scholar
• Chi BJ, Zhao DM, Liu L, et al. Downregulation of hsa_circ_0000285 serves as a prognostic biomarker for bladder cancer and is involved in cisplatin resistance. Neoplasma. 2019;66(2):197–202. doi:10.4149/neo_2018_180318N18530509102
   PubMed Web of Science ®Google Scholar
• Pan J, Xie X, Li H, Li Z, Ren C, Ming L. Detection of serum long non-coding RNA UCA1 and circular RNAs for the diagnosis of bladder cancer and prediction of recurrence. Int J Clin Exp Pathol. 2019;12(8):2951–2958.31934131
   PubMed Web of Science ®Google Scholar
• Sucu BO, Ipek OS, Kurtulus SO, Yazici BE, Karakas N, Guzel M. Synthesis of novel methyl jasmonate derivatives and evaluation of their biological activity in various cancer cell lines. Bioorg Chem. 2019;91:103146. doi:10.1016/j.bioorg.2019.10314631377389
   PubMed Web of Science ®Google Scholar
• Raviv Z, Zilberberg A, Cohen S, et al. Methyl jasmonate down-regulates survivin expression and sensitizes colon carcinoma cells towards TRAIL-induced cytotoxicity. Br J Pharmacol. 2011;164(5):1433–1444. doi:10.1111/j.1476-5381.2011.01419.x21486277
   PubMed Web of Science ®Google Scholar
• Zhang M, Su L, Xiao Z, Liu X, Liu X. Methyl jasmonate induces apoptosis and pro-apoptotic autophagy via the ROS pathway in human non-small cell lung cancer. Am J Cancer Res. 2016;6(2):187–199.27186395
   PubMed Web of Science ®Google Scholar
• Ribera-Fonseca A, Jimenez D, Leal P, et al. The anti-proliferative and anti-invasive effect of leaf extracts of blueberry plants treated with methyl jasmonate on human gastric cancer in vitro is related to their antioxidant properties. Antioxidants. 2020;9(1):45.
   Web of Science ®Google Scholar
• Farooqi AA, Butt G, Razzaq Z. Algae extracts and methyl jasmonate anti-cancer activities in prostate cancer: choreographers of ‘the dance macabre’. Cancer Cell Int. 2012;12(1):50. doi:10.1186/1475-2867-12-5023181808
   PubMedGoogle Scholar
• Xie F, Li Y, Wang M, et al. Circular RNA BCRC-3 suppresses bladder cancer proliferation through miR-182-5p/p27 axis. Mol Cancer. 2018;17(1):144. doi:10.1186/s12943-018-0892-z30285878
   PubMed Web of Science ®Google Scholar
• Li B, Xie F, Zheng FX, Jiang GS, Zeng FQ, Xiao XY. Overexpression of CircRNA BCRC4 regulates cell apoptosis and MicroRNA-101/EZH2 signaling in bladder cancer. J Huazhong Univ Sci Technolog Med Sci. 2017;37(6):886–890.29270748
   PubMedGoogle Scholar
• Su Y, Yang W, Jiang N, et al. Hypoxia-elevated circELP3 contributes to bladder cancer progression and cisplatin resistance. Int J Biol Sci. 2019;15(2):441–452. doi:10.7150/ijbs.2682630745833
   PubMed Web of Science ®Google Scholar
• Chen J, Sun Y, Ou Z, et al. Androgen receptor-regulated circFNTA activates KRAS signaling to promote bladder cancer invasion. EMBO Rep. 2020;21(4):e48467. doi:10.15252/embr.20194846732052578
   PubMed Web of Science ®Google Scholar
• Yuan W, Zhou R, Wang J, et al. Circular RNA Cdr1as sensitizes bladder cancer to cisplatin by upregulating APAF1 expression through miR-1270 inhibition. Mol Oncol. 2019;13(7):1559–1576. doi:10.1002/1878-0261.1252331131537
   PubMed Web of Science ®Google Scholar
• Li H, Krstin S, Wang S, Wink M. Capsaicin and piperine can overcome multidrug resistance in cancer cells to doxorubicin. Molecules. 2018;23(3):557.
   PubMed Web of Science ®Google Scholar
• Stefan K, Schmitt SM, Wiese M. 9-deazapurines as broad-spectrum inhibitors of the ABC transport proteins P-glycoprotein, multidrug resistance-associated protein 1, and breast cancer resistance protein. J Med Chem. 2017;60(21):8758–8780. doi:10.1021/acs.jmedchem.7b0078829016119
   PubMed Web of Science ®Google Scholar
• Nemcova-Furstova V, Kopperova D, Balusikova K, et al. Characterization of acquired paclitaxel resistance of breast cancer cells and involvement of ABC transporters. Toxicol Appl Pharmacol. 2016;310:215–228. doi:10.1016/j.taap.2016.09.02027664577
   PubMed Web of Science ®Google Scholar
• Koshkin V, Krylov SN. Correlation between multi-drug resistance-associated membrane transport in clonal cancer cells and the cell cycle phase. PLoS One. 2012;7(7):e41368. doi:10.1371/journal.pone.004136822848474
   PubMed Web of Science ®Google Scholar
• Chen Y, Scully M, Petralia G, Kakkar A. Binding and inhibition of drug transport proteins by heparin: a potential drug transporter modulator capable of reducing multidrug resistance in human cancer cells. Cancer Biol Ther. 2014;15(1):135–145. doi:10.4161/cbt.2714824253450
   PubMed Web of Science ®Google Scholar
• Choi YH, Yu AM. ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development. Curr Pharm Des. 2014;20(5):793–807.23688078
   PubMed Web of Science ®Google Scholar
• Gong P, Xu R, Zhuang Q, He X. A novel circular RNA (hsa_circRNA_102336), a plausible biomarker, promotes the tumorigenesis by sponging miR-515-5p in human bladder cancer. Biomed Pharmacother. 2020;126:110059. doi:10.1016/j.biopha.2020.11005932208321
   PubMed Web of Science ®Google Scholar
• Xie F, Zhao N, Zhang H, Xie D. Circular RNA circHIPK3 promotes gemcitabine sensitivity in bladder cancer. J Cancer. 2020;11(7):1907–1912. doi:10.7150/jca.3972232194801
   PubMed Web of Science ®Google Scholar
• Zeng Z, Zhou W, Duan L, et al. Circular RNA circ-VANGL1 as a competing endogenous RNA contributes to bladder cancer progression by regulating miR-605-3p/VANGL1 pathway. J Cell Physiol. 2019;234(4):3887–3896. doi:10.1002/jcp.2716230146736
   PubMed Web of Science ®Google Scholar
• Yang C, Wu S, Wu X, Zhou X, Jin S, Jiang H. Silencing circular RNA UVRAG inhibits bladder cancer growth and metastasis by targeting the microRNA-223/fibroblast growth factor receptor 2 axis. Cancer Sci. 2019;110(1):99–106. doi:10.1111/cas.1385730387298
   PubMed Web of Science ®Google Scholar
• Lin G, Sheng H, Xie H, et al. circLPAR1 is a novel biomarker of prognosis for muscle-invasive bladder cancer with invasion and metastasis by miR-762. Oncol Lett. 2019;17(3):3537–3547.30867795
   PubMed Web of Science ®Google Scholar
• Zhang L, Xia HB, Zhao CY, Shi L, Ren XL. Cyclic RNA hsa_circ_0091017 inhibits proliferation, migration and invasiveness of bladder cancer cells by binding to microRNA-589-5p. Eur Rev Med Pharmacol Sci. 2020;24(1):86–96.31957821
   PubMed Web of Science ®Google Scholar
• Mao W, Huang X, Wang L, et al. Circular RNA hsa_circ_0068871 regulates FGFR3 expression and activates STAT3 by targeting miR-181a-5p to promote bladder cancer progression. J Exp Clin Cancer Res. 2019;38(1):169. doi:10.1186/s13046-019-1136-930999937
   PubMed Web of Science ®Google Scholar
• Jiang Y, Wei T, Li W, Zhang R, Chen M. Circular RNA hsa_circ_0002024 suppresses cell proliferation, migration, and invasion in bladder cancer by sponging miR-197-3p. Am J Transl Res. 2019;11(3):1644–1652.30972190
   PubMed Web of Science ®Google Scholar
• Aoki M, Fujishita T. Oncogenic roles of the PI3K/AKT/mTOR axis. Curr Top Microbiol Immunol. 2017;407:153–189.28550454
   PubMed Web of Science ®Google Scholar
• Keppler-Noreuil KM, Parker VE, Darling TN, Martinez-Agosto JA. Somatic overgrowth disorders of the PI3K/AKT/mTOR pathway & therapeutic strategies. Am J Med Genet C Semin Med Genet. 2016;172(4):402–421. doi:10.1002/ajmg.c.3153127860216
   PubMed Web of Science ®Google Scholar
• Papa A, Pandolfi PP. The PTEN(-)PI3K axis in cancer. Biomolecules. 2019;9(4):153. doi:10.3390/biom9040153
   PubMed Web of Science ®Google Scholar
• Yao J, Qian K, Chen C, et al. ZNF139/circZNF139 promotes cell proliferation, migration and invasion via activation of PI3K/AKT pathway in bladder cancer. Aging. 2020;12(10):9915–9934. doi:10.18632/aging.10325632454461
   PubMedGoogle Scholar
• Yang C, Yuan W, Yang X, et al. Circular RNA circ-ITCH inhibits bladder cancer progression by sponging miR-17/miR-224 and regulating p21, PTEN expression. Mol Cancer. 2018;17(1):19. doi:10.1186/s12943-018-0771-729386015
   PubMed Web of Science ®Google Scholar
• Maik-Rachline G, Hacohen-Lev-Ran A, Seger R. Nuclear ERK: mechanism of translocation, substrates, and role in cancer. Int J Mol Sci. 2019;20(5):1194. doi:10.3390/ijms20051194
   PubMed Web of Science ®Google Scholar
• Yanchun M, Yi W, Lu W, et al. Triptolide prevents proliferation and migration of esophageal squamous cell cancer via MAPK/ERK signaling pathway. Eur J Pharmacol. 2019;851:43–51. doi:10.1016/j.ejphar.2019.02.03030779917
   PubMed Web of Science ®Google Scholar
• Qiu S, Hu W, Ma Q, Zhao Y, Li L, Ding Y. TIPE1 suppresses the invasion and migration of breast cancer cells and inhibits epithelial-to-mesenchymal transition primarily via the ERK signaling pathway. Acta Biochim Biophys Sin (Shanghai). 2019;51(10):1008–1015. doi:10.1093/abbs/gmz09931559412
   PubMed Web of Science ®Google Scholar
• Sun QY, Ding LW, Johnson K, et al. SOX7 regulates MAPK/ERK-BIM mediated apoptosis in cancer cells. Oncogene. 2019;38(34):6196–6210. doi:10.1038/s41388-019-0865-831332289
   PubMed Web of Science ®Google Scholar
• Zhong Z, Huang M, Lv M, et al. Circular RNA MYLK as a competing endogenous RNA promotes bladder cancer progression through modulating VEGFA/VEGFR2 signaling pathway. Cancer Lett. 2017;403:305–317. doi:10.1016/j.canlet.2017.06.02728687357
   PubMed Web of Science ®Google Scholar
• Peng G, Meng H, Pan H, Wang W. CircRNA 001418 promoted cell growth and metastasis of bladder carcinoma via EphA2 by miR-1297. Curr Mol Pharmacol. 2020;13. doi:10.2174/1874467213666200505093815
   Google Scholar
• Teoh SL, Das S. Notch signalling pathways and their importance in the treatment of cancers. Curr Drug Targets. 2018;19(2):128–143. doi:10.2174/138945011866617030914341928294046
   PubMed Web of Science ®Google Scholar
• Shi YR, Wu Z, Xiong K, et al. Circular RNA circKIF4A sponges miR-375/1231 to promote bladder cancer progression by upregulating NOTCH2 expression. Front Pharmacol. 2020;11:605. doi:10.3389/fphar.2020.0060532457613
   PubMed Web of Science ®Google Scholar
• Chen L, Yang X, Zhao J, et al. Circ_0008532 promotes bladder cancer progression by regulation of the miR-155-5p/miR-330-5p/MTGR1 axis. J Exp Clin Cancer Res. 2020;39(1):94. doi:10.1186/s13046-020-01592-032460831
   PubMed Web of Science ®Google Scholar
• Meyer PW, Anderson R, Ker JA, Ally MT. Rheumatoid arthritis and risk of cardiovascular disease. Cardiovasc J Afr. 2018;29(5):317–321. doi:10.5830/CVJA-2018-01829583150
   PubMed Web of Science ®Google Scholar
• Levidou G, Saetta AA, Korkolopoulou P, et al. Clinical significance of nuclear factor (NF)-κB levels in urothelial carcinoma of the urinary bladder. Virchows Arch. 2008;452(3):295–304. doi:10.1007/s00428-007-0560-y18188593
   PubMed Web of Science ®Google Scholar
• Liu H, Chen D, Bi J, et al. Circular RNA circUBXN7 represses cell growth and invasion by sponging miR-1247-3p to enhance B4GALT3 expression in bladder cancer. Aging. 2018;10(10):2606–2623. doi:10.18632/aging.10157330312173
   PubMedGoogle Scholar
• Sun M, Zhao W, Chen Z, et al. Circular RNA CEP128 promotes bladder cancer progression by regulating Mir-145-5p/Myd88 via MAPK signaling pathway. Int J Cancer. 2019;145(8):2170–2181. doi:10.1002/ijc.3231130939216
   PubMed Web of Science ®Google Scholar
• Han CT, Bao QY, Cheng SJ, Liu M, Qian HN, Li D. Circular RNA hsa_circ_0017247 acts as an oncogene in bladder cancer by inducing Wnt/beta-catenin signaling pathway. Eur Rev Med Pharmacol Sci. 2020;24(3):1081–1087.32096177
   PubMed Web of Science ®Google Scholar
• Su Y, Feng W, Zhong G, et al. ciRs-6 upregulates March1 to suppress bladder cancer growth by sponging miR-653. Aging. 2019;11(23):11202–11223. doi:10.18632/aging.10252531819015
   PubMedGoogle Scholar
• Zhang X, Liu X, Jing Z, et al. The circINTS4/miR-146b/CARMA3 axis promotes tumorigenesis in bladder cancer. Cancer Gene Ther. 2020;27(3–4):189–202. doi:10.1038/s41417-019-0085-y30723269
   PubMed Web of Science ®Google Scholar
• Lim S, Kaldis P. Cdks, cyclins and CKIs: roles beyond cell cycle regulation. Development. 2013;140(15):3079–3093. doi:10.1242/dev.09174423861057
   PubMed Web of Science ®Google Scholar
• Zheng F, Wang M, Li Y, et al. CircNR3C1 inhibits proliferation of bladder cancer cells by sponging miR-27a-3p and downregulating cyclin D1 expression. Cancer Lett. 2019;460:139–151. doi:10.1016/j.canlet.2019.06.01831255724
   PubMed Web of Science ®Google Scholar
• Sun M, Zhao W, Chen Z, et al. Circ_0058063 regulates CDK6 to promote bladder cancer progression by sponging miR-145-5p. J Cell Physiol. 2019;234(4):4812–4824. doi:10.1002/jcp.2728030362519
   PubMed Web of Science ®Google Scholar
• Aljabery F, Shabo I, Gimm O, Jahnson S, Olsson H. The expression profile of p14, p53 and p21 in tumour cells is associated with disease-specific survival and the outcome of postoperative chemotherapy treatment in muscle-invasive bladder cancer. Urol Oncol. 2018;36(12):530 e7–530 e18. doi:10.1016/j.urolonc.2018.05.025
   PubMed Web of Science ®Google Scholar
• Li P, Yang X, Yuan W, et al. CircRNA-Cdr1as exerts anti-oncogenic functions in bladder cancer by sponging microRNA-135a. Cell Physiol Biochem. 2018;46(4):1606–1616. doi:10.1159/00048920829694981
   PubMedGoogle Scholar
• Manning AL, Ganem NJ, Bakhoum SF, Wagenbach M, Wordeman L, Compton DA. The kinesin-13 proteins Kif2a, Kif2b, and Kif2c/MCAK have distinct roles during mitosis in human cells. Mol Biol Cell. 2007;18(8):2970–2979. doi:10.1091/mbc.e07-02-011017538014
   PubMed Web of Science ®Google Scholar
• Gan H, Lin L, Hu N, et al. KIF2C exerts an oncogenic role in nonsmall cell lung cancer and is negatively regulated by miR-325-3p. Cell Biochem Funct. 2019;37(6):424–431. doi:10.1002/cbf.342031328811
   PubMed Web of Science ®Google Scholar
• Song X, Zhang T, Wang X, et al. Distinct diagnostic and prognostic values of kinesin family member genes expression in patients with breast cancer. Med Sci Monit. 2018;24:9442–9464. doi:10.12659/MSM.91340130593585
   PubMed Web of Science ®Google Scholar
• Chen J, Li S, Zhou S, et al. Kinesin superfamily protein expression and its association with progression and prognosis in hepatocellular carcinoma. J Cancer Res Ther. 2017;13(4):651–659. doi:10.4103/jcrt.JCRT_491_1728901309
   PubMed Web of Science ®Google Scholar
• Yang C, Li Q, Chen X, et al. Circular RNA circRGNEF promotes bladder cancer progression via miR-548/KIF2C axis regulation. Aging. 2020;12(8):6865–6879. doi:10.18632/aging.10304732305958
   PubMedGoogle Scholar
• Dongre A, Weinberg RA. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol. 2019;20(2):69–84.30459476
   PubMed Web of Science ®Google Scholar
• Cao W, Zhao Y, Wang L, Huang X. Circ0001429 regulates progression of bladder cancer through binding miR-205-5p and promoting VEGFA expression. Cancer Biomark. 2019;25(1):101–113. doi:10.3233/CBM-18238030909190
   PubMed Web of Science ®Google Scholar
• Zhao X, Guan JL. Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis. Adv Drug Deliv Rev. 2011;63(8):610–615. doi:10.1016/j.addr.2010.11.00121118706
   PubMed Web of Science ®Google Scholar
• Jin H, He Y, Zhao P, et al. Targeting lipid metabolism to overcome EMT-associated drug resistance via integrin beta3/FAK pathway and tumor-associated macrophage repolarization using legumain-activatable delivery. Theranostics. 2019;9(1):265–278. doi:10.7150/thno.2724630662566
   PubMed Web of Science ®Google Scholar
• Tao T, Yuan S, Liu J, et al. Cancer stem cell-specific expression profiles reveal emerging bladder cancer biomarkers and identify circRNA_103809 as an important regulator in bladder cancer. Aging. 2020;12(4):3354–3370. doi:10.18632/aging.10281632065779
   PubMedGoogle Scholar
• Gu C, Zhou N, Wang Z, et al. circGprc5a promoted bladder oncogenesis and metastasis through Gprc5a-targeting peptide. Mol Ther Nucleic Acids. 2018;13:633–641. doi:10.1016/j.omtn.2018.10.00830497053
   PubMedGoogle Scholar
• Chen Q, Yin Q, Mao Y, et al. Hsa_circ_0068307 mediates bladder cancer stem cell-like properties via miR-147/c-Myc axis regulation. Cancer Cell Int. 2020;20:151. doi:10.1186/s12935-020-01235-632398967
   PubMed Web of Science ®Google Scholar
• Erdogan B, Webb DJ. Cancer-associated fibroblasts modulate growth factor signaling and extracellular matrix remodeling to regulate tumor metastasis. Biochem Soc Trans. 2017;45(1):229–236. doi:10.1042/BST2016038728202677
   PubMed Web of Science ®Google Scholar
• Pickup MW, Mouw JK, Weaver VM. The extracellular matrix modulates the hallmarks of cancer. EMBO Rep. 2014;15(12):1243–1253. doi:10.15252/embr.20143924625381661
   PubMed Web of Science ®Google Scholar
• Gilkes DM, Semenza GL, Wirtz D. Hypoxia and the extracellular matrix: drivers of tumour metastasis. Nat Rev Cancer. 2014;14(6):430–439.24827502
   PubMed Web of Science ®Google Scholar
• Liu F, Zhang H, Xie F, et al. Hsa_circ_0001361 promotes bladder cancer invasion and metastasis through miR-491-5p/MMP9 axis. Oncogene. 2020;39(8):1696–1709. doi:10.1038/s41388-019-1092-z31705065
   PubMed Web of Science ®Google Scholar
• Liu Q, Zhou Q, Zhong P. circ_0067934 increases bladder cancer cell proliferation, migration and invasion through suppressing miR-1304 expression and increasing Myc expression levels. Exp Ther Med. 2020;19(6):3751–3759.32346439
   PubMed Web of Science ®Google Scholar
• Sun J, Zhang H, Tao D, et al. CircCDYL inhibits the expression of C-MYC to suppress cell growth and migration in bladder cancer. Artif Cells Nanomed Biotechnol. 2019;47(1):1349–1356. doi:10.1080/21691401.2019.159694130968727
   PubMed Web of Science ®Google Scholar
• Wu Z, Huang W, Wang X, et al. Circular RNA CEP128 acts as a sponge of miR-145-5p in promoting the bladder cancer progression via regulating SOX11. Mol Med. 2018;24(1):40. doi:10.1186/s10020-018-0039-030134837
   PubMed Web of Science ®Google Scholar
• Liu P, Li X, Guo X, et al. Circular RNA DOCK1 promotes bladder carcinoma progression via modulating circDOCK1/hsa-miR-132-3p/Sox5 signalling pathway. Cell Prolif. 2019;52(4):e12614. doi:10.1111/cpr.1261430983072
   PubMed Web of Science ®Google Scholar
• Lefebvre V. Roles and regulation of SOX transcription factors in skeletogenesis. Curr Top Dev Biol. 2019;133:171–193.30902252
   PubMed Web of Science ®Google Scholar
• Sarkar A, Hochedlinger K. The sox family of transcription factors: versatile regulators of stem and progenitor cell fate. Cell Stem Cell. 2013;12(1):15–30. doi:10.1016/j.stem.2012.12.00723290134
   PubMed Web of Science ®Google Scholar
• Kamachi Y, Kondoh H. Sox proteins: regulators of cell fate specification and differentiation. Development. 2013;140(20):4129–4144. doi:10.1242/dev.09179324086078
   PubMed Web of Science ®Google Scholar
• Nemer M, Horb ME. The KLF family of transcriptional regulators in cardiomyocyte proliferation and differentiation. Cell Cycle. 2007;6(2):117–121. doi:10.4161/cc.6.2.371817245133
   PubMed Web of Science ®Google Scholar
• Bureau C, Hanoun N, Torrisani J, Vinel JP, Buscail L, Cordelier P. Expression and function of kruppel like-factors (KLF) in carcinogenesis. Curr Genomics. 2009;10(5):353–360. doi:10.2174/13892020978892101020119532
   PubMed Web of Science ®Google Scholar
• Park CS, Lewis A, Chen T, Lacorazza D. Concise review: regulation of self-renewal in normal and malignant hematopoietic stem cells by kruppel-like factor 4. Stem Cells Transl Med. 2019;8(6):568–574. doi:10.1002/sctm.18-024930790473
   PubMed Web of Science ®Google Scholar
• Kim CK, He P, Bialkowska AB, Yang VW. SP and KLF transcription factors in digestive physiology and diseases. Gastroenterology. 2017;152(8):1845–1875. doi:10.1053/j.gastro.2017.03.03528366734
   PubMed Web of Science ®Google Scholar
• He Q, Huang L, Yan D, et al. CircPTPRA acts as a tumor suppressor in bladder cancer by sponging miR-636 and upregulating KLF9. Aging. 2019;11(23):11314–11328. doi:10.18632/aging.10253031821171
   PubMedGoogle Scholar
• He Q, Yan D, Dong W, et al. circRNA circFUT8 upregulates krupple-like factor 10 to inhibit the metastasis of bladder cancer via sponging miR-570-3p. Mol Ther Oncolytics. 2020;16:172–187. doi:10.1016/j.omto.2019.12.01432072011
   PubMed Web of Science ®Google Scholar
• Liang H, Huang H, Li Y, Lu Y, Ye T. CircRNA_0058063 functions as a ceRNA in bladder cancer progression via targeting miR-486-3p/FOXP4 axis. Biosci Rep. 2020;40(3). doi:10.1042/BSR20193484
   Google Scholar
• Liu T, Lu Q, Liu J, et al. Circular RNA FAM114A2 suppresses progression of bladder cancer via regulating NP63 by sponging miR-762. Cell Death Dis. 2020;11(1):47. doi:10.1038/s41419-020-2226-531969560
   PubMed Web of Science ®Google Scholar
• Huang W, Lu Y, Wang F, Huang X, Yu Z. Downregulation of circular RNA hsa_circ_0000144 inhibits bladder cancer progression via stimulating miR-217 and suppressing RUNX2 expression. Gene. 2018;678:337–342. doi:10.1016/j.gene.2018.08.03630098434
   PubMed Web of Science ®Google Scholar